Notably, type 2 diabetes patients with NAFLD had serum PTX3 levels as high as patients with normal liver function illustrating an association of serum PTX3 with dyslipidemia rather than NAFLD [13, 15]. The gene discussed is PTX3; the disease is metabolic syndrome.